Standardized OTC labels could minimize line extension confusion -- APhA.
This article was originally published in The Tan Sheet
Executive Summary
STANDARDIZED OTC LABEL COULD HELP TO ELIMINATE LINE EXTENSION CONFUSION, American Pharmaceutical Association (APhA) Board of Trustees member Janet Engle maintained at a Sept. 29 FDA public hearing on OTC labeling. Consumers may "assume that a consistent brand name on an over-the-counter drug product refers to consistent active ingredients," which is not always true "given the trend toward over-the-counter brand name line extensions," Engle said.